Alligator Bioscience General Information Description. Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

A high-level overview of Alligator Bioscience AB (publ) (ALLGF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

August 25, 2020 - 5:09 am. LUND, Sweden, Aug. 25, 2020-- Alligator Bioscience (Nasdaq Stockholm: ATORX) will give status updates and details on the recent clinical development plans for the clinical drug candidates mitazalimab, ATOR-1015 and ATOR-1017 on a virtual R&D Day on August 27. "These clinical plans provide an excellent opportunity for Alligator to have two or even three competitive Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016. Alligator Bioscience håller tempot uppe. Efter publiceringen av 2019 års resultat, kan marknaden konstatera att bioteknikbolaget Alligator Bioscience har kassa nog att driva utvecklingsarbetet framåt i planerad takt.

Alligator bioscience stock

1 Apr 2021 YTD %, -20,00. Symbol, ATORX. Market, Stockholm. Market Cap (mil), 532,84. Volatility, 0,41. Beta, 0,67.

Change in number of shares and votes in Alligator Bioscience Alligator Bioscience. Analyst Stock Pitch.

redaktionen. Bildkälla: Stockfoto Alligator Bioscience är ned 7,6 procent på börsen i dag och har fallit närmare 36 procent sedan årsskiftet.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Ownership data is sourced through FactSet.

1 day ago

Janssen-arkiv - BioStock — Bild: Sarasota County Sheriff/AP/TT I veckans avsnitt gästas vi av Alligator Biosciences vd BioStock Studio: Alligator Biosciences ordförande om de senaste nyheterna. 16 april 2021 kl 11:30. Lundabaserade Alligator Bioscience meddelade under Alligator Bioscience utser Peter Ellmark till ny CSO - Alligator — av Alligator Bioscience.

Alligator's pipeline includes the two key assets ATOR-1017 and mitazalimab. Furthermore, there are two partnered assets: ALG.APV-527 in co-development with Aptevo Therapeutics Inc. and AC101 in clinical development by Shanghai Henlius Biotech Inc. BioStock: Alligator säkrar den långsiktiga utvecklingen tis, apr 14, 2020 12:03 CET. Alligator Bioscience ökar fokus på den kliniska utvecklingsportföljen genom en rad kostnadsreducerande åtgärder som kommer att spara bolaget drygt 80 Mkr årligen. Biotech company Alligator Bioscience is developing tumour-directed immunotherapies with two of their projects soon in clinical phase II. Recently, the company announced two new additions to their management team, Peter Ellmark as CSO and Christina Reimer as CMO. LUND, Sweden, April 3, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the board of directors has decided to postpone the Annual General Meeting to June 1, 2021, in connection with that Søren Bregenholt takes office as new CEO of Alligator. LUND, Sweden, April 3, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the board of directors has decided to postpone the Annual General Meeting to June 1 Senaste nyheter om - Alligator Bioscience, aktieanalys, kursutveckling och rapporter. Alligator Bioscience komplett bolagsfakta & börsnyheter från Analysguiden. 2020-12-23 · ALLGF: Get the latest Alligator Bioscience stock price and detailed information including ALLGF news, historical charts and realtime prices. LUND, Sweden, March 18, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søren Bregenholt, Ph.D.
Frakt posten 10 kg

BioStock: Interimsdata från Alligator på AACR satte fart på aktien tis, maj 05, 2020 08:44 CET. Alligator Bioscience presenterade nyligen sin finansiella status i samband med delårsrapporten för första kvartalet. Alligator Bioscience är ett forskningsbaserat bioteknikbolag som använder en patenterad teknologi för att utveckla biologiska läkemedelskandidater inom inflammation och cancer. Bolaget är verksamt i den tidigare delen av läkemedelsutvecklingskedjan. Alligator Bioscience General Information Description.

The Company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies.
Tofthagaskolan matsedel

euro utveckling prognos
escobar inc iphone
hamburgerrestaurang varberg
det som aldrig sker
ogiltiga sedlar 2021

Alligator Bioscience Ab (LSE:0RK9)Intraday Stock Chart. Friday 19 March 2021. LUND, Sweden, March 18, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Annual Report for 2020 has been published. The Annual Report is attached as a PDF and is available on the company's website, https

0% Other Total Stock Holdings, 18.